CLINICAL EVENTS CALENDAR
- Nov 18,2009Nov 21,2009Yucatan Pediatric Seminar11/18/2009 - 12:2111/21/2009 - 12:21
Northwest Podiatric Foundation
Yucatan Crippled Children's Project
Merida, Mexico
Hyatt Regency Merida Hotel
1-866-286-NWPF - Jan 10,2010Jan 17,2010Winter Seminar at Sea01/10/2010 - 12:2401/17/2010 - 12:24
Northwest Podiatric Foundation
Southern Caribbean Cruise
RCCL - The Adventure of the Seas
1-866-286-NWPF - Apr 17,2010Apr 20,20102010 SAWC Spring04/17/2010 - 11:2304/20/2010 - 11:23website:
Gaylord Palms Hotel and Convention Center
Orlando, FL - Jul 15,2010Jul 18,2010The 2010 APMA Annual Scientific Meeting07/15/2010 - 13:2607/18/2010 - 13:26website:
Washington State Convention & Trade Center
Seattle, Washington
Non-Accredited Education
Managing the Diabetic Foot: A Clinical and Economic View Complimentary Archived Webcast
Non-Accredited
Understanding Collagen Dressings and their Benefit in Wound Care
Complimentary Archived Webcast
non-accredited
Diabetes Watch
Can Nanotechnology Have An Impact For Patients With Diabetes?
Regardless of their specialty, clinicians will encounter patients who are affected by diabetes mellitus, infection and wound healing issues. Therefore, the emerging, evolving science of nanomedicine and how this technology could positively enhance patient outcomes would be of great interest to all physicians including DPMs.
Current Concepts In Treating Diabetic Foot Osteomyelitis
Diabetic foot osteomyelitis continues to be one of the more challenging entities to diagnose and treat accurately. Although there are established clinical practice guidelines set forth by the Infectious Diseases Society of America (IDSA), deviations from these guidelines often exist from one treatment facility to the next.1
Current Concepts In Offloading Diabetic Foot Ulcers
As the prevalence of diabetes mellitus increases worldwide, there will be a concomitant increase in the development of the lower extremity manifestations of the disease process. In the United States alone, there are currently an estimated 24 million patients living with diabetes.1,2 Given the reported 15 percent lifetime incidence for the development of lower extremity ulcerations in this patient population, this equates to approximately 3.6 million diabetic foot ulcers (DFUs).3
Is HbA1c A Reliable Test In Patients With Diabetes And Renal Disease?
Reportedly 23.6 million individuals in the United States (or 8 percent of the American population) are affected by diabetes.1 Many of those with diabetes will develop related comorbidities such as microvascular pathology in the retina, renal glomeruli and peripheral nerves. Other comorbidities include accelerated atherosclerotic microvascular disease affecting arteries that supply the heart, brain and lower extremities.2,3
Can New Hemostatic Dressings Facilitate Sharp Debridement In High-Risk Patients?
Sharp debridement is a critical step to promote healing and allow the body to repair chronic wounds as naturally and healthily as possible. Removing necrotic tissue and biofilm from the surface of chronic wounds converts chronic wounds into acute ones, effectively “resetting” the wound healing cascade and allowing the healing process to take place.
Is HBOT Cost-Effective For Diabetic Foot Ulcers?
It is estimated that Medicare spends $1.5 billion annually to treat diabetic foot ulcers (DFU).1 The debate continues on the cost effectiveness of immediate amputation in comparison with “conservative treatment” using a variety of modalities.
Understanding How The Achilles Tendon Affects Plantar Pressure
Approximately 23.6 million people in the United States have diabetes, according to the 2007 statistics from the American Diabetes Association.1 Many of these patients have an associated comorbidity of obesity and, all too often, Achilles tendon contracture.
As we age, the tendon naturally tightens. However, diabetes exacerbates this tightening process as increased blood sugar levels deposit glucose in the collagen of the tendon, greatly reducing its elasticity. Obesity can also contribute to the tightening of the posterior muscle group, which i
Current Insights On Classifying Charcot Arthropathy
Before the advent of insulin, death from diabetes occurred early in the disease process. Now people with diabetes are living longer and long-term complications of the disease are more common. One such complication is Charcot arthropathy and since the early report by Jordan linking it to diabetes, the number of case reports has steadily increased.1
Although the etiology of Charcot arthropathy is largely unknown, it is well recognized that this condition can occur in conjunction with any peripheral neuropathy. Researchers have found that Charcot
How Depression And Anxiety Affect Patient Adherence
We have all bemoaned non-adherent patients with out-of-control blood sugars who nod agreeably and then ignore everything we say. Not surprisingly, their wounds heal poorly and discouragement sets in with these patients. Their behavior appears to defy logic until we look at how prevalent depression and anxiety disorders are among patents with diabetes and how these disorders affect healing. The picture begins to make even more sense when we consider the effect of prolonged hyperglycemia on the brain.
Extensive studies have established a strong link between
Exploring The Potential Of Gene Therapy For Patients With Diabetes
Gene therapy has entered the forefront of medicine and there may be potential benefits in all fields of healthcare. The potential for gene therapy to target disease has vastly expanded since the first successful human treatment for severe combined immune deficiency (SCID) emerged in 1990.
In podiatric medicine, one proposed target that has devastating consequences is the diabetic foot ulcer. As diabetes mellitus continues to become more common within the podiatric population, the necessity to care for wounds and focus on limb preservation is becoming mor
William Fishco, DPM, FACFAS
Michelle L. Butterworth, DPM, FACFAS
Lake Charles, Louisiana
Hampton Bays and Long Island, New York
Various Locations- Indiana , Ohio
CME Showcase
"Current Concepts In Healing Chronic Diabetic Foot Ulcerations"
A Complimentary On-Demand CE/CME Webcast This activity is supported by an educational grant from Advanced Biohealing. To access this Webcast, visit www.naccme.com/program/n-550/ |
 Current Concepts In Diagnosing And Treating MRSA In The Diabetic Foot This activity is supported by an education grant from Pfizer. To access this activity, visit www.naccme.com/program/n-528/ |
 MRSA And Diabetic Foot Wounds: Where Do We Go From Here?Archived Accredited Webcast with Q&A This activity is supported by an educational grant from Pfizer. This activity is sponsored by the North American Center For Continuing Medical Education (NACCME). |
 PERIPHERAL ARTERIAL DISEASE (PAD) AND CRITICAL LIMB ISCHEMIA (CLI):Managing Vascular and Wound Healing Challenges with Current and Emerging Technologies Archived Accredited Webcast with Q&A This activity is supported by an educational grant from Baxter Healthcare Corporation. |
Podiatry Today News Wire
- Friday, September 12, 2008 - 15:29
REVIEW OUR OTHER
HMP BRANDS
Check out our other resources for healthcare professionals of all specialties.
